BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeChristopher B, Park SH, Vong L, Bamford D, Cho HH, Duvadie R, Fedolak A, Hogan C, Honda T, Pandey P, Rozhitskaya O, Su L, Tomlinson E, Wallace I. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration. Bioorg Med Chem Lett 2019;29:991-4. [PMID: 30824200 DOI: 10.1016/j.bmcl.2019.02.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Gay EA, Guan D, Van Voorhies K, Vasukuttan V, Mathews KM, Besheer J, Jin C. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System. J Med Chem 2022. [PMID: 35594150 DOI: 10.1021/acs.jmedchem.2c00508] [Reference Citation Analysis]
2 Leysen H, Walter D, Clauwaert L, Hellemans L, van Gastel J, Vasudevan L, Martin B, Maudsley S. The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease. Int J Mol Sci 2022;23:4387. [PMID: 35457203 DOI: 10.3390/ijms23084387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guan D, Rahman MT, Gay EA, Vasukuttan V, Mathews KM, Decker AM, Williams AH, Zhan CG, Jin C. Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies. J Med Chem 2021;64:17866-86. [PMID: 34855388 DOI: 10.1021/acs.jmedchem.1c01081] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Lin G, Feng Y, Cai X, Zhou C, Shao L, Chen Y, Chen L, Liu Q, Zhou Q, Bathgate RAD, Yang D, Wang MW. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist. Molecules 2021;26:7511. [PMID: 34946593 DOI: 10.3390/molecules26247511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wong WLE, Dawe GS, Young AH. The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review. Neurosci Biobehav Rev 2021;131:429-50. [PMID: 34537263 DOI: 10.1016/j.neubiorev.2021.09.028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Woodward ORM, Gribble FM, Reimann F, Lewis JE. Gut peptide regulation of food intake - evidence for the modulation of hedonic feeding. J Physiol 2021. [PMID: 34152020 DOI: 10.1113/JP280581] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Ricardo-Silgado ML, McRae A, Acosta A. Role of Enteroendocrine Hormones in Appetite and Glycemia. Obes Med 2021;23:100332. [PMID: 34179564 DOI: 10.1016/j.obmed.2021.100332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lin L, Lin G, Zhou Q, Bathgate RAD, Gong GQ, Yang D, Liu Q, Wang MW. Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists. Bioorg Chem 2021;110:104782. [PMID: 33730669 DOI: 10.1016/j.bioorg.2021.104782] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Lin GY, Lin L, Cai XQ, Dai AT, Zhu Y, Li J, Liu Q, Yang DH, Bathgate RAD, Wang MW. High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4. Acta Pharmacol Sin 2020;41:1328-36. [PMID: 32235863 DOI: 10.1038/s41401-020-0390-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Eiden LE, Gundlach AL, Grinevich V, Lee MR, Mecawi AS, Chen D, Buijs RM, Hernandez VS, Fajardo-Dolci G, Zhang L. Regulatory peptides and systems biology: A new era of translational and reverse-translational neuroendocrinology. J Neuroendocrinol 2020;32:e12844. [PMID: 32307768 DOI: 10.1111/jne.12844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Praveen P, Bathgate RAD, Hossain MA. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4. Sci Rep 2019;9:17828. [PMID: 31780677 DOI: 10.1038/s41598-019-53707-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]